Remove 2022 Remove Generic Medicine Remove Packaging
article thumbnail

Parallel import of medicinal products: regulatory update

European Pharmaceutical Review

This is due to the regulatory requirements imposed on parallel imported medicinal products in various Member States, the fulfilment of which often requires repackaging. Repackaging a medicinal product… means that the trademark is reapplied by an entity other than the trademark proprietor.”

article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

It noted that US law requires complete manufacturing addresses to be printed on generic drug packaging and listed in the FDAs Orange Book database. The FDA has an established office in India overseeing the number of qualified manufacturers supplying generic medicines to the US.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What happened to all the antibiotics?

pharmaphorum

These include allowing the exceptional supply of certain medicines that may not be authorised in a particular Member State or granting full or partial exemptions to certain labelling and packaging requirements to address severe problems in respect of the availability of some medicines.”

article thumbnail

Halting Europe’s essential medicines manufacturing exodus

European Pharmaceutical Review

The recent update to the EC Urban Waste Directive, part of the environment package ‘Towards Zero Pollution,’ 4 has a disproportionate producer responsibility principle that will incur considerable extra costs. This is likely to make some essential medicines and APIs economically unsustainable to manufacture.

article thumbnail

Shaping the future of India’s pharmaceutical operations

Express Pharma

Over the past decade and more, Indias pharmaceutical sector has become the worlds largest supplier of generic medicines, with exports growing faster than the global average. This supported the industry to consistently and reliably maintain essential supplies in critical times such as the COVID-19 pandemic between 2020 and 2022.

article thumbnail

STAT+: ‘Like playing the lottery’: A mixed picture for laid-off life sciences workers in Massachusetts

STAT

But the   drumbeat of layoffs in 2022   has only grown louder this year. biopharma firms cut about 6,000 jobs in 2022 and 11,000 so far this year. percent to about 114,000 in 2022, compared to nearly 107,000 the year before, according to a  report released Sept. He estimated U.S. Absolutely.” ”

Vaccines 319